Deals
Roche Sees ‘No Urgency’ to Buy Rest of Chugai, CFO Says
This article is for subscribers only.
A steady flow of small deals makes sense for Roche Holding AG, and the Swiss drugmaker is in no hurry to buy the rest of Chugai Pharmaceutical Co. that it doesn’t already own, Chief Financial Officer Alan Hippe said.
Roche, the world’s biggest maker of cancer drugs, will continue to “fill gaps” in its portfolio and invest in treatments for Alzheimer’s disease, Hippe said in an interview in San Francisco, where health executives are attending a JPMorgan Chase & Co. annual conference.